ADCYAP1 and Miyoshi myopathy: In our study, we demonstrated a significant decrease in the PACAP levels in patients with MM compared with age- and gender-matched healthy controls, which may open up the future possibility of using PACAP as a potential biomarker for the diagnosis of MM.